Cell cycle phase specificity and therapeutic effectiveness of polyamine synthesis inhibitors.
D000818:Animals; D002453:Cell Cycle / Q000187:drug effects*; D000518:Eflornithine; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines / Q000096:biosynthesis / Q000502:physiology*
D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; D009952:Ornithine; D000518:Eflornithine